Introduction
Nowadays, it has been widely accepted that cancer is one of the major threat to the health of people worldwide which could cause millions of deaths every year [1] . In spite of great efforts have been devoted to the creation of therapeutic tools, chemotherapy is still the dominant treatment method. In this case, the search of effective chemotherapy drugs with low cost, high selectivity, lack of undesirable side effects, and low cytotoxicity is of high importance [2, 3] . The cancer cell resistance to anticancer agents and the toxicity of modern chemotherapy make the sciences worldwide search for new drugs and cure methods for such an insidious disease [4] .
Metal-organic coordination polymers have been rapidly developed in the past decades due to their fascinating structures or topologies, especially their potential use as functional materials in various key domains such as asymmetrical catalysis, energy gas storage and separation, molecular and ionic magnetism, guest-dependent luminescence, and so on [5] [6] [7] [8] [9] [10] . Many efforts have been devoted to selecting suitable ligands because they play important roles in the guiding the formation of the obtained produces with targeted chemical and physical characters [11] . The organic ligands containing N atoms have received considerable attention for the versatile binding modes as a bridging linker between inorganic moieties [12, 13] . In recent years, [(pzTp)Fe(CN) 3 ] has been used as a pre-designed molecular building block to construct heterometallic coordination polymers, which show interesting structural diversity and outstand properties [14] . For instance, Oshio and co-workers reported a series of heterometallic coordination polymers constructed from the [(pzTp)Fe(CN) 3 ] building blocks, which demonstrate both electric and magnetic bistability [15] . In this work, we chose [(pzTp)Fe(CN) 3 ] to react with different metal ions and different N-donor organic 
Materials and Methods

Instruments and Chemicals
A Rigaku D/MAX 2500V diffractometer (Rigaku Corporation, Tokyo, Japan) was used to collect the powder X-ray diffraction (PXRD) curves. An Oxford Xcalibur E diffractometer with Mo-Kα radiation (λ = 0.71073) was employed to collect the single crystal X-ray diffraction data. A Perkin Elmer model 240C (PerkinElmer, Norwalk, CT, America) instrument was employed to obtain the element analyses (C, H, and N) results. All the chemicals in this study were commercially available and used as received. Bu4N[pzTpFe(CN)3], Me4TACD, and Bim ligands were bought from Ji'nan Heng Hua Technology Co., Ltd. (Ji Nan, China) at analytical grade. Mn(NO3)2 (aq, 50% w/w) and Cu(NO3)2·6H2O were purchased from Alfa Aesar Chemical Reagent company (Tianjin, China) at analytical grade. The synthesis process of complex 3 was similar to that of 2, except that the equal amount of Mn(NO3)2 (aq, 50% w/w) was used to replace Cu(NO3)2·6H2O. Analytical calcd for 3 (C72H68B2MnFe2N28O10): H, 3.66; C, 43.56; N, 34.63; found: H 3.49, C 43.42, N 34.55.
Preparation and Characterization for Compounds
Crystal Structure Determination
An Oxford Xcalibur E diffractometer with graphite monochromatized Mo K radiation (0.71073 Å) was used to collect the reflection data of 1-3 at 298 K. The direct method in the XS program was used 
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Crystal Structure Determination
An Oxford Xcalibur E diffractometer with graphite monochromatized Mo K radiation (0.71073 Å) was used to collect the reflection data of 1-3 at 298 K. The direct method in the XS program was used to get the initial structural modes and the least-squares method in XL program was used to refine the structural models. All the H atoms on the organic ligands were generated geometrically, and all non-hydrogen atoms in the two structures were treated anistropically. For the highly-disordered nature of the seven water molecules in 1, they could not be figured out appropriately from the Fourier map, so the SQUEEZE manipulation in the software PLATON(version: 1.18) was used to remove their electronic contribution. The SQUEEZE calculation result reveals that each unit cell contains 1256 electrons, corresponding to 78.5 electrons (7.85 H 2 O) per molecular unit, which is near to the value derived from the element analyses (eight H 2 O per molecular unit). Table 1 shows the crystal data and the structure refinements. Pertinent crystal data and structural refinement results for compounds 1-3 were summarized in Table 1 . 
Antitumor Activity
Four human liver cancer cell (HepG2, Bel-7402, SMMC7721, and MHCC97) lines were developed in a RPMI 1460 medium supplemented with 10% fetal calf serum, 0.1 g/L streptomycin and 0.1 g/L penicillin. The above systems were incubated in a humidified incubator with air and CO 2 (95:5, v:v) at 37 • C. RPMI 1640 was used to dilute the cell to a concentration of 5 × 10 4 cells/mL. The 96-well cell culture at a volume of 100 µL per cell was used to seed the cells. Then the system was incubated for 24 h at 37 • C in 5% CO 2 . The MTT solution (0.5 mg/mL, 150 µL) was added to each well tested and the plates were cultured for 4 h. Afterwards, 100 µL of dimethyl sulfoxide (DMSO) was transferred into each well to dissolve the samples. A microplate reader (Per-kinElmer, Waltham, MA, USA) was used to record the absorbance at a wavelength of 450 nm, which is further used in the calculation of the cell relative viability. Each parallel experiment was carried out for at least three times to obtain the mean values.
Results and Discussion
Molecular Structure
An evaporation method was used in the synthesis of the single crystals of 1 in a beaker. The X-ray single-crystal investigation demonstrates that 1 locates in the orthorhombic crystal system, the Fddd space group with a large cell volume of 27,342 Å 3 . The molecular unit of 1 is composed of neutral [MnMe 4 3 ] − anion, the six-coordinated Fe(III) ion is bonded to three N donors from there pz linkers with the leaving coordinating sites completed via the C donors on three CN ions (Figure 2a) . The Fe-N bond distances locate in the region of 1.990 (2) (Figure 2b) . Furthermore, the adjacent trinuclear cluster are interacted with each other though the π-π interaction of the pz rings to form a 1D chain-like supermolecular structure (Figure 2c ). (Figure 2b) . Furthermore, the adjacent trinuclear cluster are interacted with each other though the π-π interaction of the pz rings to form a 1D chain-like supermolecular structure (Figure 2c ). Complexes 2 and 3 could be obtained in a moderate yield using a slow volatilization method, and their structures were fully studied by the X-ray single crystalline diffraction technology, which shows that both complexes are isomeric and possess similar 1D chain-like framework. Thus, herein we only describe the structure of complex 2 in detail. X-ray single-crystal diffraction analyses revealed that complex 2 locates in the monoclinic crystal system, P21/n space group and demonstrates a 1D chain-like structure. The crystal structure comprises of two components: one is the [Fe III (pzTp)(CN)3] − anion and the other is the 1D Cu(II) chains that formed by the connection of the Cu(II) ions by the Bim ligands along the a axis. As shown in Figure 3a Complexes 2 and 3 could be obtained in a moderate yield using a slow volatilization method, and their structures were fully studied by the X-ray single crystalline diffraction technology, which shows that both complexes are isomeric and possess similar 1D chain-like framework. Thus, herein we only describe the structure of complex 2 in detail. X-ray single-crystal diffraction analyses revealed that complex 2 locates in the monoclinic crystal system, P2 1 /n space group and demonstrates a 1D chain-like structure. The crystal structure comprises of two components: one is the [Fe III (pzTp)(CN) 3 ] − anion and the other is the 1D Cu(II) chains that formed by the connection of the Cu(II) ions by the Bim ligands along the a axis. As shown in Figure 3a , in the [Fe III (pzTp)(CN) 3 ] − anion, the six-coordinated Fe(III) atom is coordinated to three N donors from three independence pz linkers with the leaving binding sites completed via the C donors on the three CN ions. The Fe-N bond lengths are in the region of 1.953(3) to 1.995(3) Å and the Fe-C bond distance varies from 1.925(4) to 1.932(4) Å, respectively, which are comparable to those reported in the literature, which are also formed as Fe III tricyanide metal-organic complexes. As for the Cu 2+ ion in the 1D chain (Figure 3b) 3 ] − anion, which is further linked with the adjacent Cu 2+ ions though four Bim ligands in a double-walled model. Such connection modes results in the formation of the 1D chain-like framework of 2. The 1D chains are further stacked in an ABAB fashion in the three-dimensional direction to form a 3D supermolecular network (Figure 3c ). We carried out the power X-ray diffraction measurement for the three compounds, and the results are shown in Figure 4 . The well match between their simulated peaks with the peaks of their prepared samples confirmed the phase purity of their prepared samples. respectively, which are comparable to those reported in the literature, which are also formed as Fe III tricyanide metal-organic complexes. As for the Cu 2+ ion in the 1D chain (Figure 3b) anion, which is further linked with the adjacent Cu 2+ ions though four Bim ligands in a double-walled model. Such connection modes results in the formation of the 1D chain-like framework of 2. The 1D chains are further stacked in an ABAB fashion in the three-dimensional direction to form a 3D supermolecular network (Figure 3c ). We carried out the power X-ray diffraction measurement for the three compounds, and the results are shown in Figure 4 . The well match between their simulated peaks with the peaks of their prepared samples confirmed the phase purity of their prepared samples. respectively, which are comparable to those reported in the literature, which are also formed as Fe III tricyanide metal-organic complexes. As for the Cu 2+ ion in the 1D chain (Figure 3b) (Figure 3c ). We carried out the power X-ray diffraction measurement for the three compounds, and the results are shown in Figure 4 . The well match between their simulated peaks with the peaks of their prepared samples confirmed the phase purity of their prepared samples. 
In Vitro Cytotoxicity Study against the Cancer Cells
In order to preliminarily evaluate the anticancer efficacies of the three complexes (1-3), their tumor cell growth inhibition activity was assessed in vitro against four human liver cancer cells (HepG2, Bel-7402, SMMC7721, and MHCC97) by MTT assay with the cisplatin drug as the refer. Expose time was set to 48 h and the cell growth inhibition activity effects of cisplatin were used to make a comparison with the results of 1-3. DMSO was used to dissolve the compounds at the concentration of 1 µM, and the diluted solution was added into the cell culture.
The data, which represent means ± SEM of three independent tests carried out in duplicate, are plotted in Figure 5a . A descending order could be observed for the anti-proliferative activity of the test complexes toward each type of the tumor cell lines used, which might be ascribed to the measured concentration required to inhibit tumor cell proliferation by 50% (IC 50 µg/mL). From the results above, we can conclude that the new compounds 1-3 demonstrate comparable growth inhibition activity toward all four types of cancer cells (IC 50 = 34-56 µg/mL) with the reference drug.
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To probe the cytotoxicity of the as-prepared three compounds toward the human normal cells in vitro, oral epidermal cells (human normal cells) were selected to incubate with 1-3 for 24 h under different concentrations (0-30 μg/mL). Figure 5b shows the cell viabilities of the three complexes, which are all above 84% even at a concentration of 30 μg/mL. The above experimental results indicate that the three complexes showed low cytotoxicity toward the human normal cells. 
Conclusions
The X-ray single crystal study demonstrates reveals that the metal-organic complex 1 is a trinuclear cluster that consists of two (pzTp)Fe(CN)3 units and one MnMe4TACD unit that connected by the CN ions, while compounds 2 and 3 are isostructural and demonstrate 1D chain-like structure that formed by the connection of the (pzTp)Fe(CN)3 units and the 1D M(II)-chains though the CN ions. Furthermore, the in vitro cytotoxicity of compounds 1-3 was studied against four human liver cancer cells (HepG2, Bel-7402, SMMC7721, and MHCC97) via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) assay experiments, which reveals their potential use as anticancer drugs. 
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